Home › Funds › EMERALD MUTUAL FUND ADVISERS TRUST › TVTX

EMERALD MUTUAL FUND ADVISERS TRUST position in TVTX

TRAVERE THERAPEUTICS INC · Health Care

EMERALD MUTUAL FUND ADVISERS TRUST reported holding 984,847 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$58.0M, representing 2.37% of its reported portfolio and ranking #2 among its reported holdings. EMERALD MUTUAL FUND ADVISERS TRUST has disclosed TVTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)984.85K sh
Reported value held$57.99M
Portfolio Weight2.37%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EMERALD MUTUAL FUND ADVISERS TRUST's TVTX position evolved

EMERALD MUTUAL FUND ADVISERS TRUST first disclosed a stake in TVTX in Q3 2023 at 764,603 shares (US$6.8M). The position peaked in Q2 2026 at 1,032,024 shares, worth US$58.6M. Across 13 filings, EMERALD MUTUAL FUND ADVISERS TRUST increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 984,847 shares valued at US$58.0M — a reduction of -47,177 shares quarter over quarter.. Notable position changes include a 74% increase in Q1 2024 (shares rose 7% over the following quarter), a 29% trim in Q2 2024 (shares rose 70% over the following quarter), a 26% increase in Q3 2024 (shares rose 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 764.60K $6.84M New
Q4 2023 764.60K $6.87M Hold
Q1 2024 1.33M $10.24M Add
Q2 2024 941.26K $7.74M Reduce
Q3 2024 1.19M $16.59M Add
Q4 2024 1.10M $19.19M Reduce
Q1 2025 1.12M $20.10M Add
Q2 2025 1.14M $16.89M Add
Q3 2025 1.20M $28.70M Add
Q4 2025 948.46K $36.24M Reduce
Q1 2026 945.03K $28.08M Hold
Q2 2026 1.03M $58.63M Add
Q3 2026 984.85K $57.99M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TVTX and 13F data

TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TVTX

All TVTX fund holders →

FAQ

How long has EMERALD MUTUAL FUND ADVISERS TRUST held TVTX?

EMERALD MUTUAL FUND ADVISERS TRUST has disclosed TVTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EMERALD MUTUAL FUND ADVISERS TRUST's current position in TVTX?

As of Q3 2026, EMERALD MUTUAL FUND ADVISERS TRUST holds 984.85K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $57.99M, representing 2.37% of its reported portfolio and ranking #2.

Has EMERALD MUTUAL FUND ADVISERS TRUST been buying or selling TVTX?

In the latest 13F filing (Q3 2026), EMERALD MUTUAL FUND ADVISERS TRUST reduced its position in TVTX. The position peaked in Q2 2026 at 1.03M shares.

Which other funds hold TVTX?

Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.